The global Cancer Immunotherapy market size is estimated at 157.91 billion USD with a CAGR of 9.9% during the forecasted period from 2021-2028.
Table of Content 1. Market Introduction 1.1. Executive Summary 1.2. Market Definition 1.3. Market Scope 2. Research Methodology 2.1. Primary Research 2.2. Research Methodology 2.3. Assumptions & Exclusions 2.4. Secondary data sources 3. Global Cancer Immunotherapy Market Overview 3.1. Report Segmentation & Scope 3.2. Key Market Trend 3.3. Drivers 3.4. Restraints 3.5. Opportunities 3.6. Porter’s Five Forces Analysis 3.6.1. Bargaining Power of Supplier 3.6.2. Bargaining Power of Buyer 3.6.3. Threat of Substitute 3.6.4. Threat of New Entrants 3.6.5. Competitive Rivalry 3.7 PESTEL Analysis 3.7.1. Political Landscape 3.7.2. Economic Landscape 3.7.3. Technological Landscape 3.7.4. Environmental Landscape 3.7.5. Social Landscape 3.8. Market Share Analysis 4. Global Cancer Immunotherapy Market, By Cancer Type 4.1. Overview 4.2. Breast Cancer 4.2.1. Market Size & Forecast, 2019-2026 4.3. Melanoma 4.3.1. Market Size & Forecast, 2019-2026 4.4. Lung Cancer 4.4.1. Market Size & Forecast, 2019-2026 4.5. Colorectal Cancer 4.5.1. Market Size & Forecast, 2019-2026 4.6. Prostate Cancer 4.6.1. Market Size & Forecast, 2019-2026 4.7. Ovarian Cancer 4.7.1. Market Size & Forecast, 2019-2026 4.8. Head & Neck 4.8.1. Market Size & Forecast, 2019-2026 4.9. Pancreatic Cancer 4.9.1. Market Size & Forecast, 2019-2026 5. Global Cancer Immunotherapy Market, By Product Type 5.1. Overview 5.2. Immunomodulators 5.2.1. Market Size & Forecast, 2019-2026 5.3. Monoclonal Antibodies 5.3.1 Market Size & Forecast, 2019-2026 5.4. Oncolytic viral Therapies & Cancer Vaccines 5.4.1 Market Size & Forecast, 2019-2026 6. Global Cancer Immunotherapy Market, Region 6.1. Overview 6.1.1. Global Market Size & Forecast, 2019-2026 6.2. North America Cancer Immunotherapy Market 6.2.1. North America Market Size & Forecast, 2019-2026, By Country 6.2.2. North America Market Size & Forecast, 2019-2026, By Cancer Type 6.2.3. North America Market Size & Forecast, 2019-2026, By Product Type 6.2.4. U.S. 6.2.4.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.2.4.2. Market Size and Forecast, 2019-2026, By Product Type 6.2.5. Canada 6.2.5.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.2.5.2. Market Size and Forecast, 2019-2026, By Product Type 6.3. Europe Cancer Immunotherapy Market 6.3.1. Europe Market Size & Forecast, 2019-2026, By Country 6.3.2. Europe Market Size & Forecast, 2019-2026, By Cancer Type 6.3.3. Europe Market Size & Forecast, 2019-2026, By Product Type 6.3.4. Germany 6.3.4.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.3.4.2. Market Size and Forecast, 2019-2026, By Product Type 6.3.5. France 6.3.5.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.3.5.2. Market Size and Forecast, 2019-2026, By Product Type 6.3.6. UK 6.3.6.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.3.6.2. Market Size and Forecast, 2019-2026, By Product Type 6.3.7. Italy 6.3.7.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.3.7.2. Market Size and Forecast, 2019-2026, By Product Type 6.3.8. Spain 6.3.8.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.3.8.2. Market Size and Forecast, 2019-2026, By Product Type 6.3.9. Rest of Europe 6.3.9.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.3.9.2. Market Size and Forecast, 2019-2026, By Product Type 6.4. Asia-Pacific Cancer Immunotherapy Market 6.4.1. Asia-Pacific Market Size & Forecast, 2019-2026, By Country 6.4.2. Asia-Pacific Market Size & Forecast, 2019-2026, By Cancer Type 6.4.3. Asia-Pacific Market Size & Forecast, 2019-2026, By Product Type 6.4.4. Japan 6.4.4.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.4.4.2. Market Size and Forecast, 2019-2026, By Product Type 6.4.5. China 6.4.5.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.4.5.2. Market Size and Forecast, 2019-2026, By Product Type 6.4.6. Australia 6.4.6.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.4.6.2. Market Size and Forecast, 2019-2026, By Product Type 6.4.7. India 6.4.7.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.4.7.2. Market Size and Forecast, 2019-2026, By Product Type 6.4.8. South Korea 6.4.8.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.4.8.2. Market Size and Forecast, 2019-2026, By Product Type 6.4.9. Rest of Asia-Pacific 6.4.9.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.4.9.2. Market Size and Forecast, 2019-2026, By Product Type 6.5. South America Cancer Immunotherapy Market 6.5.1. South America Market Size & Forecast, 2019-2026, By Country 6.5.2. South America Market Size & Forecast, 2019-2026, By Cancer Type 6.5.3. South America Market Size & Forecast, 2019-2026, By Product Type 6.5.4. Brazil 6.5.4.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.5.4.2. Market Size and Forecast, 2019-2026, By Product Type 6.5.5. Argentina 6.5.5.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.5.5.2. Market Size and Forecast, 2019-2026, By Product Type 6.5.6. Rest of South America 6.5.6.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.5.6.2. Market Size and Forecast, 2019-2026, By Product Type 6.6. Middle East & Africa Cancer Immunotherapy Market 6.6.1. Middle East & Africa Market Size & Forecast, 2019-2026, By Country 6.6.2. Middle East & Africa Market Size & Forecast, 2019-2026, By Cancer Type 6.6.3. Middle East & Africa Market Size & Forecast, 2019-2026, By Product Type 6.6.4. GCC Countries 6.6.4.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.6.4.2. Market Size and Forecast, 2019-2026, By Product Type 6.6.5. Egypt 6.6.5.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.6.5.2. Market Size and Forecast, 2019-2026, By Product Type 6.6.6. South Africa 6.6.6.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.6.6.2. Market Size and Forecast, 2019-2026, By Product Type 6.6.7. Rest of Middle East & Africa 6.6.7.1. Market Size and Forecast, 2019-2026, By Cancer Type 6.6.7.2. Market Size and Forecast, 2019-2026, By Product Type 9. Company Profile 9.1. Bayer AG 9.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 9.1.2. Product Information, and Specification 9.1.3. Financial Performance 9.1.4. Strategic Initiatives 9.2. Bristol-Myers Squibb 9.3. AstraZeneca 9.4. Amgen Inc. 9.5. F. Hoffman La Roche 9.6 Johnson & Johnson 9.7 Novartis 9.8 Merck and Co. 9.9 Eli Lilly and Co. 9.10 Pfizer 10. List of Tables Table 1 Global Cancer Immunotherapy Market Share, By Cancer Type, 2016-2026 ($Billion) Table 2 Global Cancer Immunotherapy Market Share, By Product Type, 2016-2026 ($Billion) Table 3 Global Cancer Immunotherapy Market Value, 2016-2026 ($Billion) Table 4 North America, Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion) Table 5 North America, Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion) Table 6 North America Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 7 North America Cancer Immunotherapy Market Share Value, By Product Type 2016-2026 ($Billion) Table 8 U.S. Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 9 U.S. Cancer Immunotherapy Market Share Value, By Product Type 2016-2026 ($Billion) Table 10 Canada Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 11 Canada Cancer Immunotherapy Market Share Value, By Product Type 2016-2026 ($Billion) Table 12 Europe Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion) Table 13 Europe Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion) Table 14 Europe Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 15 Europe Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 16 UK Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 17 UK Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 18 Germany Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 19 Germany Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 20 France Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 21 France Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 22 Italy Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 23 Italy Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 24 Rest of Europe Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 25 Rest of Europe Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 26 Asia Pacific Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion) Table 27 Asia Pacific Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion) Table 28 Asia Pacific Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 29 Asia Pacific Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 30 India Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 31 India Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 32 China Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 33 China Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 34 Japan Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 35 Japan Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 36 South Korea Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 37 South Korea Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 38 Rest of Asia Pacific Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 39 Rest of Asia Pacific Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 40 South America Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion) Table 41 South America Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion) Table 42 South America Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 43 South America Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 44 Brazil Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 45 Brazil Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 46 Argentina Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 47 Argentina Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 48 Mexico Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 49 Mexico Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 50 Rest of South America, Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 51 Rest of South America Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 52 Middle East & Africa Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion) Table 53 Middle East & Africa Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion) Table 54 Middle East & Africa Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 55 Middle East & Africa Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 56 GCC Countries Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 57 GCC Countries Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 58 Africa Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 59 Africa Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 60 Rest of Middle East & Africa Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion) Table 61 Rest of Middle East & Africa Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion) Table 62 Recent Developments 10. List of Figures Figure 1 Global Cancer Immunotherapy Market Overview Figure 2 Global Cancer Immunotherapy Market Segmentation Figure 3 Global Cancer Immunotherapy Market Drivers Figure 4 Global Cancer Immunotherapy Market Restraints Figure 5 Global Cancer Immunotherapy Market Porter’s Analysis Figure 6 Global Cancer Immunotherapy Market share, By Cancer Type, 2018 VS 2026 (%) Figure 7 Global Cancer Immunotherapy Market share, By Product Type, 2018 VS 2026 (%) Figure 8 U.S. Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 9 Canada Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 10 U.K. Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 11 Germany Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 12 France Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 13 Italy Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 14 Rest of Europe Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 15 India Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 16 China Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 17 Japan Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 18 South Korea Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 19 Rest of Asia Pacific Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 20 Brazil Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 21 Argentina Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 22 Rest of South America Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 23 GCC Countries Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 24 Africa Cancer Immunotherapy Market share, 2016-2026 ($Billion) Figure 25 Rest of Middle East & Africa Cancer Immunotherapy Market share, 2016-2026 ($Billion)